← Open Payments lookup

GRACE MENSAH: Open Payments

NPI 1932988680 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,396 in 126 payments from 17 companies in 2025. Trend: 2023 $734 · 2024 $2,982 · 2025 $2,396

Food & beverage: $2,295Education: $101
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc7$348
Otsuka America Pharmaceutical, Inc.23$299
Teva Pharmaceuticals USA, Inc.8$265
Neurocrine BioSciences, Inc.7$263
ABBVIE INC.30$254
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$223
Vanda Pharmaceuticals Inc.8$140
Alkermes, Inc.10$122
E.R. Squibb & Sons, L.L.C.5$108
Axsome Therapeutics, Inc.5$99

Products named: INGREZZA, VRAYLAR, INVEGA SUSTENNA, CAPLYTA, REXULTI, FANAPT, AUSTEDO XR, COBENFY.

Industry payments across ID — which companies pay providers there.